Investment
Features
FeesSafety
Academy
More
Pluang+

REX Osprey XRP ETF drops 60% in first year amid broader market challenges.

Market News
18 Sep 2026
Finbold
View Source
Bearish
REX Osprey XRP ETF drops 60% in first year amid broader market challenges.

The REX Osprey XRP ETF (XRPR), the first U.S. spot XRP ETF, has lost about 60% since its launch on September 18, 2025, with its price falling from $25.73 to $10.57. XRP's price also declined roughly 59% from $3.08 to $1.33 over the same period. Despite this, U.S. spot XRP ETFs have seen $1.71 billion in net inflows historically and hold $1.39 billion in assets, showing ongoing institutional interest. The losses largely reflect broader market struggles, regulatory uncertainty, and macroeconomic issues rather than a lack of ETF demand.

The first U.S. XRP ETF marks its one-year anniversary after losing about 60% since launch. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 18, 2026 21:36 WIB: 46 of 50 major cryptocurrencies rose today. Notable movers include SAND up 10.39%, GRT up 10.27%, and XTZ up 10.15%.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
2 hours ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
3 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token surged 10.5% to $91.20, reaching a new all-time high of $92.56 after Hyperliquid launched manual borrowing of USDC and USDT using HYPE and Bitcoin as collateral. The platform offers a 65% loan-to-value ratio for HYPE, higher than Bitcoin's...

Market News
Bullish
4 hours ago
CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech Vanadium Mining Corp. has engaged Mercator Geological Services to prepare an independent technical report on its Campbell-Crotser fluorspar project in Kentucky, following National Instrument 43-101 standards. The report will detail geology,...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App